Sevenless Therapeutics ApS: Financial statements 2025
CVR: 43311999
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
Sevenless Therapeutics ApS (CVR 43311999) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK -197,098 and a net result of DKK -159,621 compared with DKK -597,179 the year before. Equity in the 2025 report amounted to DKK -644,863. The company had 3 employees in the financial year.
- Gross Profit
- DKK -197,098
- Profit/Loss
- DKK -159,621
- Equity
- DKK -644,863
- Total Assets
- DKK 12,407,289
- Employees
- 3
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | -197K | -160K | -645K | 3 |
| 2024 | - | -260K | -597K | -485K | 0 |
| 2023 | - | -692K | -103K | 112K | 0 |
Official annual report
How creditworthy is Sevenless Therapeutics ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
Sevenless Therapeutics ApS has published its annual report for 2024. Gross profit came to DKK -260,403, and the net result was DKK -597,179.
About Sevenless Therapeutics ApS
Sevenless Therapeutics ApS is a Danish company of the type Anpartsselskab based in København N, founded in 2022. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Alasdair Naylor, Alexander Robert Leech and Neil Benson. The company is owned by Sevenless Therapeutics Limited. According to the 2025 annual report, the company had an average of 3 employees. In 2025, the company reported a gross profit of DKK -197,098 and a net result of DKK -159,621 compared with DKK -597,179 the year before. Equity in the 2025 report amounted to DKK -644,863.